Physician

Brian E Michael, MD

According to 2025 Medicare claims, Brian Michael, MD (NPI: 1942237722) practices endocrinology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is ADAMS ENDOCRINOLOGY ASSOCIATES LLC (NPI: 1871094623; TIN: 82-4555547) and primary practice location at 17325-8599.

Michael's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 444 traditional Medicare patients, billed 1,549 HCPCS/CPT codes, and received $127,041 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 4,637 prescription claims across 457 beneficiaries totaling $2,251,840 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 521 claims. Open Payments data shows 146 records totaling $15,490. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,009,479 and ending at $2,251,840. For DME billing, reported payments moved sharply higher in recent years, from $16,590 to $161,881.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	623	3,246	$133,081
2016	639	2,755	$125,649
2017	252	892	$20,401
2018	N/R	N/R	N/R
2019	159	412	$42,759
2020	242	826	$69,287
2021	327	1,028	$96,928
2022	335	1,093	$98,324
2023	361	1,247	$99,339
2024	444	1,549	$127,041

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	431	3,684	$1,009,479
2016	470	5,053	$2,348,439
2017	401	2,577	$969,486
2018	35	136	$41,200
2019	101	547	$1,221,427
2020	194	1,685	$2,259,780
2021	269	2,359	$2,110,675
2022	319	2,874	$1,415,906
2023	377	3,526	$2,062,630
2024	457	4,637	$2,251,840

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	105	354	$22,358
2016	152	415	$18,725
2017	89	296	$19,042
2018	N/R	15	$480
2019	N/R	33	$3,989
2020	34	182	$29,015
2021	63	342	$52,941
2022	60	443	$77,338
2023	64	562	$114,228
2024	108	521	$165,788

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	78	78	$147
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	145	211	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	373	759	$87
76536	Ultrasound scan of head and neck soft tissue	124	136	$75
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	112	290	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	328	10,996	$393,223
Ozempic	Semaglutide	214	11,717	$370,286
Jardiance	Empagliflozin	230	12,769	$236,891
Tresiba Flextouch U-200	Insulin Degludec	64	4,960	$145,861
Trulicity	Dulaglutide	64	2,466	$81,288

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	76	400	$146,759
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	18	$6,452
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	24	$5,943
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	17	17	$3,149
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	23	$2,603

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	146	$15,490	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian E. Michael, MD?

Tedicare shows public-source Medicare data for Brian E. Michael, MD (NPI 1942237722), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian E. Michael, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian E. Michael, MD?

Brian E. Michael, MD is linked to ADAMS ENDOCRINOLOGY ASSOCIATES LLC (billing NPI 1871094623) in the available physician profile data.

Does Brian E. Michael, MD have Open Payments data?

Brian E. Michael, MD has 146 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.